SI-BONE, Inc. (SIBN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

SI-BONE, Inc. (SIBN) is down 29.4% since the beginning of the year. At $14 per share, SIBN is trading 36.4% below its 52-week high of $22. Investors who bought $1,000 worth of SIBN shares 5 years ago would now be looking at an investment worth $459.

SI-BONE, Inc. (SIBN) has returned -29.41% so far this year and -26.35% over the past 12 months.

Based on dividend-adjusted daily data since Oct 17, 2018, SIBN's average daily return is +0.04%, while the average monthly return is +0.67%. At this rate, an investment would double in approximately 8.7 years.

Historically, 46% of months were positive and 54% were negative. The best month was May 2025 with a return of +38.5%, while the worst month was Mar 2020 at -38.1%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 6 months.

On a daily basis, SIBN closed higher 49% of trading days. The best single day was May 12, 2026 with a return of +19.7%, while the worst single day was Nov 8, 2022 at -24.3%.

SI-BONE, Inc. has an annualized alpha of -5.61%, beta of 1.06, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since October 18, 2018.

• This stock participated in 108.25% of S&P 500 Index downside but only 43.49% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.15 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

SIBN ranks 19 for risk / return — in the bottom 19% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for SI-BONE, Inc. (SIBN) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the SI-BONE, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the SI-BONE, Inc. was 68.77%, occurring on Nov 9, 2022. The portfolio has not yet recovered.

The current SI-BONE, Inc. drawdown is 61.29%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of SI-BONE, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how SI-BONE, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.